Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Robin

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
JAMA Ophthalmology|August 22, 2018
Collaboration Is Needed to Improve the Quality of Eye Care and Eliminate InequitiesAlan L Robin
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 6, 2002
An accurate comparison of bimatoprost's efficacy and adverse effectsAlan L Robin
JAMA Ophthalmology|July 29, 2016
Public Health Policy Lessons From OklahomaAlan L Robin
American Journal of Ophthalmology|June 6, 2003
A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaAlan L Robin
Ophthalmology|May 10, 2005
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?Alan L Robin, David Covert
Current Opinion in Ophthalmology|April 17, 2003
Update on prostaglandin analogsCamille Hylton, Alan L Robin
Current Medical Research and Opinion|May 20, 2006
Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprostDavid Covert, Alan L Robin
American Journal of Ophthalmology|December 21, 2016
Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma or Ocular Hypertension: A Randomized TrialHoward S Barnebey, Alan L Robin
Ophthalmology|June 25, 2017
Re: Haripriya et al.: Long-term posterior capsule opacification reduction with square-edge polymethylmethacrylate intraocular lens: randomized controlled study (Ophthalmology. 2017;124:295-302)Alan L Robin, Joshua D Stein
Ophthalmology. Glaucoma|November 6, 2024
Should We Use Disposable Tonometers and Gonioprisms in the Office?Emily M Schehlein, Alan L Robin
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
JAMA Ophthalmology|August 22, 2018
Collaboration Is Needed to Improve the Quality of Eye Care and Eliminate InequitiesAlan L Robin
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 6, 2002
An accurate comparison of bimatoprost's efficacy and adverse effectsAlan L Robin
JAMA Ophthalmology|July 29, 2016
Public Health Policy Lessons From OklahomaAlan L Robin
American Journal of Ophthalmology|June 6, 2003
A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaAlan L Robin
Ophthalmology|May 10, 2005
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?Alan L Robin, David Covert
Current Opinion in Ophthalmology|April 17, 2003
Update on prostaglandin analogsCamille Hylton, Alan L Robin
Current Medical Research and Opinion|May 20, 2006
Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprostDavid Covert, Alan L Robin
American Journal of Ophthalmology|December 21, 2016
Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma or Ocular Hypertension: A Randomized TrialHoward S Barnebey, Alan L Robin
Ophthalmology|June 25, 2017
Re: Haripriya et al.: Long-term posterior capsule opacification reduction with square-edge polymethylmethacrylate intraocular lens: randomized controlled study (Ophthalmology. 2017;124:295-302)Alan L Robin, Joshua D Stein
Ophthalmology. Glaucoma|November 6, 2024
Should We Use Disposable Tonometers and Gonioprisms in the Office?Emily M Schehlein, Alan L Robin
Pageof 16